202 related articles for article (PubMed ID: 21159660)
1. Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.
Zhang S; Chitu V; Stanley ER; Elliott BE; Greer PA
Cancer Res; 2011 Feb; 71(4):1465-73. PubMed ID: 21159660
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatase receptor type O expression in the tumor niche correlates with reduced tumor growth, angiogenesis, circulating tumor cells and metastasis of breast cancer.
Liu Z; Hou J; Ren L; He J; Sun B; Sun LZ; Wang S
Oncol Rep; 2015 Apr; 33(4):1908-14. PubMed ID: 25646811
[TBL] [Abstract][Full Text] [Related]
3. Modeling triple-negative breast cancer heterogeneity: Effects of stromal macrophages, fibroblasts and tumor vasculature.
Norton KA; Jin K; Popel AS
J Theor Biol; 2018 Sep; 452():56-68. PubMed ID: 29750999
[TBL] [Abstract][Full Text] [Related]
4. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.
Delfino FJ; Stevenson H; Smithgall TE
J Biol Chem; 2006 Mar; 281(13):8829-35. PubMed ID: 16455651
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of the c-Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells.
Kanda S; Miyata Y; Kanetake H; Smithgall TE
Int J Oncol; 2009 Jan; 34(1):89-96. PubMed ID: 19082481
[TBL] [Abstract][Full Text] [Related]
6. Vascular defects in gain-of-function fps/fes transgenic mice correlate with PDGF- and VEGF-induced activation of mutant Fps/Fes kinase in endothelial cells.
Sangrar W; Mewburn JD; Vincent SG; Fisher JT; Greer PA
J Thromb Haemost; 2004 May; 2(5):820-32. PubMed ID: 15099290
[TBL] [Abstract][Full Text] [Related]
7. FES/FER kinase signaling in hematopoietic cells and leukemias.
Craig AW
Front Biosci (Landmark Ed); 2012 Jan; 17(3):861-75. PubMed ID: 22201778
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
9. A new signaling pathway (JAK-Fes-phospholipase D) that is enhanced in highly proliferative breast cancer cells.
Ye Q; Kantonen S; Henkels KM; Gomez-Cambronero J
J Biol Chem; 2013 Apr; 288(14):9881-9891. PubMed ID: 23404507
[TBL] [Abstract][Full Text] [Related]
10. Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and beta1 integrin receptors.
Smith JA; Samayawardhena LA; Craig AW
Cell Signal; 2010 Mar; 22(3):427-36. PubMed ID: 19892014
[TBL] [Abstract][Full Text] [Related]
11. FES kinase promotes mast cell recruitment to mammary tumors via the stem cell factor/KIT receptor signaling axis.
Kwok E; Everingham S; Zhang S; Greer PA; Allingham JS; Craig AW
Mol Cancer Res; 2012 Jul; 10(7):881-91. PubMed ID: 22589410
[TBL] [Abstract][Full Text] [Related]
12. The contrasting oncogenic and tumor suppressor roles of FES.
Greer PA; Kanda S; Smithgall TE
Front Biosci (Schol Ed); 2012 Jan; 4(2):489-501. PubMed ID: 22202072
[TBL] [Abstract][Full Text] [Related]
13. fps/fes knockout mice display a lactation defect and the fps/fes tyrosine kinase is a component of E-cadherin-based adherens junctions in breast epithelial cells during lactation.
Truesdell PF; Zirngibl RA; Francis S; Sangrar W; Greer PA
Exp Cell Res; 2009 Oct; 315(17):2929-40. PubMed ID: 19732771
[TBL] [Abstract][Full Text] [Related]
14. FES kinases are required for oncogenic FLT3 signaling.
Voisset E; Lopez S; Chaix A; Georges C; Hanssens K; Prébet T; Dubreuil P; De Sepulveda P
Leukemia; 2010 Apr; 24(4):721-8. PubMed ID: 20111072
[TBL] [Abstract][Full Text] [Related]
15. Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
Olvedy M; Tisserand JC; Luciani F; Boeckx B; Wouters J; Lopez S; Rambow F; Aibar S; Thienpont B; Barra J; Köhler C; Radaelli E; Tartare-Deckert S; Aerts S; Dubreuil P; van den Oord JJ; Lambrechts D; De Sepulveda P; Marine JC
J Clin Invest; 2017 Jun; 127(6):2310-2325. PubMed ID: 28463229
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 accelerates M2 macrophage infiltration and angiogenesis in tumors.
Jia W; Kidoya H; Yamakawa D; Naito H; Takakura N
Am J Pathol; 2013 May; 182(5):1821-31. PubMed ID: 23499465
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine kinase FES is an essential effector of KITD816V proliferation signal.
Voisset E; Lopez S; Dubreuil P; De Sepulveda P
Blood; 2007 Oct; 110(7):2593-9. PubMed ID: 17595334
[TBL] [Abstract][Full Text] [Related]
18. Mouse Breast Carcinoma Monocytic/Macrophagic Myeloid-Derived Suppressor Cell Infiltration as a Consequence of Endothelial Dysfunction in
He Q; Jamalpour M; Bergquist E; Anderson RL; Gustafsson K; Welsh M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768912
[TBL] [Abstract][Full Text] [Related]
19. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Joshi S; Singh AR; Zulcic M; Durden DL
Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
[TBL] [Abstract][Full Text] [Related]
20. Tissue Factor: Old and New Links with Cancer Biology.
Versteeg HH
Semin Thromb Hemost; 2015 Oct; 41(7):747-55. PubMed ID: 26408927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
